Poster Presentation at the 2026 Crohn's & Colitis Congress® Showcases Use of Causal Machine Learning and IBD Plexus® to Optimize Trial Execution BOSTON, Jan. 22, 2026 /PRNewswire/ -- PhaseV, a leader in AI/ML for clinical development, is today presenting new study results demonstrating...
Hence then, the article about phasev demonstrates how ai driven site selection and real time analytics reduce recruitment uncertainty and accelerate ibd clinical trials was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( PhaseV Demonstrates How AI-Driven Site Selection and Real-Time Analytics Reduce Recruitment Uncertainty and Accelerate IBD Clinical Trials )
Also on site :
- Legendary Rock Band Adds 40 More Dates to Massive Farewell Tour
- Pentagon considering re-naming Iran war ‘Sledgehammer’ if ceasefire collapses
- Stop Guessing Which Cooking Oil to Use. Experts Explain When to Use Each Type